Capricor stock drops as FDA cancels advisory meeting on Duchenne therapy; leadership changes and regulatory tensions fuel uncertainty.

And more health news stories you need to start your week.

Good morning! Today, we get deeper into the ousting of Nicole Verdun at the FDA, see promise from Vertex’s cell therapy for ...

Capricor Therapeutics $8.26 275.3% Roth Capital Boobalan Pachaiyappan 56 %$31 → $31 Reiterates Buy → Buy Get Alert 06/17/2025 WSM Buy Now Williams-Sonoma $158.84 7.03% Evercore ISI Group ...